Microsoft is in a better place ever since the new CEO took over. He is finally building Microsoft out into the cloud in a business environment and making new changes so its a welcomed change to see the share price rise.

As for Amazon well they just keep posting losses by spending way too much. Amazon should spend some of their cash to create new ideas and keep company going but they spend way too much and they need to tone it down a bit. I think investors of Amazon had finally had enough of the continuous spending with no profits.

I agree this week has been a better week in itself. Also The ebola headline on Thursday has slight effect on bringing down the DOW at the end by 100 points but the DOW still closed up positive for the day. Even today on Friday the DOW went up despite the new case of ebola. Eventually these risk headlines have less and less negative effect after being known for so long.

Yes I think it is insider trading. I mean you first set yourself up with a nice size stake in a company then wait a year or however many years and take it out. The problem with this is that you would be considered an insider because you place a huge stake and you know that you are going to buy it out. Just not plausible in the eyes of the law.

Well that can't be good! I don't think this comes as a surprise considering even the NASDAQ had a few problems with IPO's and other outages.

Well I agree with you. Here's why I think he's wrong as well Apple just refreshes Iphone products and hasn't created anything new. The rest of Apple's life will be refreshing Iphones and Ipads. Toda's earnings report though positive didn't even budge the share price of Apple as I see investors believe that Apple's sales are already baked into the share price.

Inovio Pharmaceuticals (INO) and Tekmira Pharmaceuticals (TKMR) both IMO have a bright future regardless of Ebola treatments. Although short term Tekmira will trade based off its ebola drug TKM-EBola and traders should be cautious if something goes wrong. But for Tekmira Investors regardless the company has an amazing future with its LNP technology platform.

I would like to think that Tekmira is in good shape because it uses lipid nanoparticle delivery -- LNP. LNP is already being used by Alnylam for TTR-mediated Amyloidosis = rare disease in patients. So Tekmira using RNAi (RNA interference) may have the upper hand. But I also like Inovio's tech and Sarepta's tech.

Wow just announced after hours first Ebola Case in U.S. Confirmed. Tekmira (TKMR), NewLink Genetics(NLNK), and Sarepta Therapeutics (SRPT) are all up after hours on this news. Tekmira itself is up 20% as of this comment writing, things may get worse before they get better. Ebola needs to be dealt with!